This page in English
Laddar profil information

Publikationer

Germline variants in IL4, MGMT and AKT1 are associated with prostate cancer-specific mortality: An analysis of 12,082 prostate cancer cases
Fitzgerald Lm, Zhao S, Leonardson A, Geybels Ms, Kolb S, Lin Dw, et al
Prostate cancer and prostatic diseases 2018;():-

Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts
Seibert Tm, Fan Cc, Wang Y, Zuber V, Karunamuni R, Parsons Jk, et al
BMJ (Clinical research ed.) 2018;360():j5757-

Alcohol consumption and prostate cancer incidence and progression: A Mendelian randomisation study
Brunner C, Davies Nm, Martin Rm, Eeles R, Easton D, Kote-jarai Z, et al
International journal of cancer 2017;140(1):75-85

E-Science technologies in a workflow for personalized medicine using cancer screening as a case study
Spjuth O, Karlsson A, Clements M, Humphreys K, Ivansson E, Dowling J, et al
Journal of the American Medical Informatics Association : JAMIA 2017;24(5):950-957

Estimating Heritability of Prostate Cancer-Specific Survival Using Population-Based Registers
Szulkin R, Clements Ms, Magnusson Pke, Wiklund Fe, Kuja-halkola R
The Prostate 2017;77(8):900-907

gsSKAT: Rapid gene set analysis and multiple testing correction for rare-variant association studies using weighted linear kernels
Larson Nb, Mcdonnell S, Cannon Albright L, Teerlink C, Stanford J, Ostrander Ea, et al
Genetic epidemiology 2017;41(4):297-308

Height, selected genetic markers and prostate cancer risk: results from the PRACTICAL consortium
Lophatananon A, Stewart-brown S, Kote-jarai Z, Olama Aaa, Garcia Sb, Neal De, et al
British journal of cancer 2017;117(5):734-743

Identification of 19 new risk loci and potential regulatory mechanisms influencing susceptibility to testicular germ cell tumor
Litchfield K, Levy M, Orlando G, Loveday C, Law Pj, Migliorini G, et al
Nature genetics 2017;49(7):1133-1140

Identification of a Novel Autoimmune Peptide Epitope of Prostein in Prostate Cancer
Pin E, Henjes F, Hong Mg, Wiklund F, Magnusson P, Bjartell A, et al
Journal of proteome research 2017;16(1):204-216

Investigating the possible causal role of coffee consumption with prostate cancer risk and progression using Mendelian randomization analysis
Taylor Ae, Martin Rm, Geybels Ms, Stanford Jl, Shui I, Eeles R, et al
International journal of cancer 2017;140(2):322-328

Mendelian randomisation analysis provides no evidence for a relationship between adult height and testicular cancer risk
Levy M, Hall D, Sud A, Law P, Litchfield K, Dudakia D, et al
Andrology 2017;5(5):914-922

Meta-analysis of five genome-wide association studies identifies multiple new loci associated with testicular germ cell tumor
Wang Z, Mcglynn Ka, Rajpert-de Meyts E, Bishop Dt, Chung Cc, Dalgaard Md, et al
Nature genetics 2017;49(7):1141-1147

SNP interaction pattern identifier (SIPI): an intensive search for SNP-SNP interaction patterns
Lin Hy, Chen Dt, Huang Py, Liu Yh, Ochoa A, Zabaleta J, et al
Bioinformatics (Oxford, England) 2017;33(6):822-833

Assessing the role of insulin-like growth factors and binding proteins in prostate cancer using Mendelian randomization: Genetic variants as instruments for circulating levels
Bonilla C, Lewis Sj, Rowlands Ma, Gaunt Tr, Davey Smith G, Gunnell D, et al
International journal of cancer 2016;139(7):1520-33

Atlas of prostate cancer heritability in European and African-American men pinpoints tissue-specific regulation
Practical Consortium, Gusev A, Shi H, Kichaev G, Pomerantz M, Li F, et al
NATURE COMMUNICATIONS 2016;:10979-

Blood lipids and prostate cancer: a Mendelian randomization analysis
Bull Cj, Bonilla C, Holly Jm, Perks Cm, Davies N, Haycock P, et al
Cancer medicine 2016;5(6):1125-36

Body mass index in relation to serum prostate-specific antigen levels and prostate cancer risk
Bonn Se, Sjölander A, Tillander A, Wiklund F, Grönberg H, Bälter K
International journal of cancer 2016;139(1):50-7

Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations
Fehringer G, Kraft P, Pharoah Pd, Eeles Ra, Chatterjee N, Schumacher Fr, et al
Cancer research 2016;76(17):5103-14

Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array
Practical Consortium, Uk Protect Study Collaborators, Uk Genetic Prostate Canc Study Col, Saunders Ej, Dadaev T, Leongamornlert Da, et al
BRITISH JOURNAL OF CANCER 2016;114(8):945-52

Gene regulatory mechanisms underpinning prostate cancer susceptibility
Whitington T, Gao P, Song W, Ross-adams H, Lamb Ad, Yang Y, et al
Nature genetics 2016;48(4):387-97

Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types
Kar Sp, Beesley J, Amin Al Olama A, Michailidou K, Tyrer J, Kote-jarai Z, et al
Cancer discovery 2016;6(9):1052-67

Oncologic Outcomes After Robot-assisted Radical Prostatectomy: A Large European Single-centre Cohort with Median 10-Year Follow-up
Rajan P, Hagman A, Sooriakumaran P, Nyberg T, Wallerstedt A, Adding C, et al
European urology focus 2016;():-

PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS
Southey Mc, Goldgar De, Winqvist R, Pylkäs K, Couch F, Tischkowitz M, et al
Journal of medical genetics 2016;53(12):800-811

Polyunsaturated fatty acids and prostate cancer risk: a Mendelian randomisation analysis from the PRACTICAL consortium
Khankari Nk, Murff Hj, Zeng C, Wen W, Eeles Ra, Easton Df, et al
British journal of cancer 2016;115(5):624-31

Post hoc Analysis for Detecting Individual Rare Variant Risk Associations Using Probit Regression Bayesian Variable Selection Methods in Case-Control Sequencing Studies
Larson Nb, Mcdonnell S, Albright Lc, Teerlink C, Stanford J, Ostrander Ea, et al
Genetic epidemiology 2016;40(6):461-9

Pubertal development and prostate cancer risk: Mendelian randomization study in a population-based cohort
Bonilla C, Lewis Sj, Martin Rm, Donovan Jl, Hamdy Fc, Neal De, et al
BMC medicine 2016;14():66-

REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense Variants
Ioannidis Nm, Rothstein Jh, Pejaver V, Middha S, Mcdonnell Sk, Baheti S, et al
American journal of human genetics 2016;99(4):877-885

Telomere structure and maintenance gene variants and risk of five cancer types
Karami S, Han Y, Pande M, Cheng I, Rudd J, Pierce Bl, et al
International journal of cancer 2016;139(12):2655-2670

Ten- and 15-yr Prostate Cancer-specific Mortality in Patients with Nonmetastatic Locally Advanced or Aggressive Intermediate Prostate Cancer, Randomized to Lifelong Endocrine Treatment Alone or Combined with Radiotherapy: Final Results of The Scandinavian Prostate Cancer Group-7
Scandinavian Prostate Canc Grp-7 I, Fossa Sd, Wiklund F, Klepp O, Angelsen A, Solberg A, et al
EUROPEAN UROLOGY 2016;70(4):684-691

The roles of stress and social support in prostate cancer mortality
Jan M, Bonn Se, Sjölander A, Wiklund F, Stattin P, Holmberg E, et al
Scandinavian journal of urology 2016;50(1):47-55

The Stockholm-3 (STHLM3) Model can Improve Prostate Cancer Diagnostics in Men Aged 50-69 yr Compared with Current Prostate Cancer Testing
Eklund M, Nordström T, Aly M, Adolfsson J, Wiklund P, Brandberg Y, et al
European urology focus 2016;():-

A differential protein solubility approach for the depletion of highly abundant proteins in plasma using ammonium sulfate
Bollineni Rc, Guldvik Ij, Grönberg H, Wiklund F, Mills Ig, Thiede B
The Analyst 2015;140(24):8109-17

A Large-Scale Analysis of Genetic Variants within Putative miRNA Binding Sites in Prostate Cancer
Stegeman S, Amankwah E, Klein K, O'mara Ta, Kim D, Lin Hy, et al
Cancer discovery 2015;5(4):368-79

Associations of prostate cancer risk variants with disease aggressiveness: results of the NCI-SPORE Genetics Working Group analysis of 18,343 cases
Helfand B, Roehl K, Cooper P, Mcguire B, Fitzgerald L, Cancel-tassin G, et al
HUMAN GENETICS 2015;134(4):439-50

Cross Cancer Genomic Investigation of Inflammation Pathway for Five Common Cancers: Lung, Ovary, Prostate, Breast, and Colorectal Cancer
Hung Rj, Ulrich Cm, Goode El, Brhane Y, Muir K, Chan At, et al
Journal of the National Cancer Institute 2015;107(11):-

Genetic determinants of telomere length and risk of common cancers: a Mendelian randomization study
Zhang C, Doherty Ja, Burgess S, Hung Rj, Lindström S, Kraft P, et al
Human molecular genetics 2015;24(18):5356-66

Genome-wide association study of prostate cancer-specific survival
Szulkin R, Karlsson R, Whitington T, Aly M, Gronberg H, Eeles Ra, et al
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2015;24(11):1796-800

Identification of four new susceptibility loci for testicular germ cell tumour
Litchfield K, Holroyd A, Lloyd A, Broderick P, Nsengimana J, Eeles R, et al
Nature communications 2015;6():8690-

Integration of multiethnic fine-mapping and genomic annotation to prioritize candidate functional SNPs at prostate cancer susceptibility regions
Han Y, Hazelett Dj, Wiklund F, Schumacher Fr, Stram Do, Berndt Si, et al
Human molecular genetics 2015;24(19):5603-18

Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans
Amin Al Olama A, Dadaev T, Hazelett Dj, Li Q, Leongamornlert D, Saunders Ej, et al
Human molecular genetics 2015;24(19):5589-602

Physical Activity and Survival among Men Diagnosed with Prostate Cancer
Bonn Se, Sjolander A, Lagerros Yt, Wiklund F, Stattin P, Holmberg E, et al
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 2015;24(1):57-64

Polymorphisms In The Nitric-Oxide Synthase 2 Gene And Prostate Cancer Pathogenesis
Ryk C, De Verdier P, Montgomery E, Peter Wiklund N, Wiklund F, Grönberg H
Redox biology 2015;5():419-

Prediction of Individual Genetic Risk to Prostate Cancer Using a Polygenic Score
Practical Consortium, Australian Prostate Canc Bioresour, Szulkin R, Whitington T, Eklund M, Aly M, et al
PROSTATE 2015;75(13):1467-74

Prostate cancer screening in men aged 50-69 years (STHLM3): a prospective population-based diagnostic study
Gronberg H, Adolfsson J, Aly M, Nordstrom T, Wiklund P, Brandberg Y, et al
LANCET ONCOLOGY 2015;16(16):1667-76

Serum Levels of Human MIC-1/GDF15 Vary in a Diurnal Pattern, Do Not Display a Profile Suggestive of a Satiety Factor and Are Related to BMI
Tsai Vw, Macia L, Feinle-bisset C, Manandhar R, Astrup A, Raben A, et al
PloS one 2015;10(7):e0133362-

The effects of height and BMI on prostate cancer incidence and mortality: a Mendelian randomization study in 20,848 cases and 20,214 controls from the PRACTICAL consortium
Davies Nm, Gaunt Tr, Lewis Sj, Holly J, Donovan Jl, Hamdy Fc, et al
Cancer causes & control : CCC 2015;26(11):1603-16

Two new loci and gene sets related to sex determination and cancer progression are associated with susceptibility to testicular germ cell tumor
Kristiansen W, Karlsson R, Rounge Tb, Whitington T, Andreassen Bk, Magnusson Pk, et al
Human molecular genetics 2015;24(14):4138-46

A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer
Al Olama Aa, Kote-jarai Z, Berndt Si, Conti Dv, Schumacher F, Han Y, et al
Nature genetics 2014;46(10):1103-9

A population-based assessment of germline HOXB13 G84E mutation and prostate cancer risk
Karlsson R, Aly M, Clements M, Zheng L, Adolfsson J, Xu J, et al
European urology 2014;65(1):169-76

A prostate cancer susceptibility allele at 6q22 increases RFX6 expression by modulating HOXB13 chromatin binding
Huang Q, Whitington T, Gao P, Lindberg Jf, Yang Y, Sun J, et al
Nature genetics 2014;46(2):126-35

Association analysis of 9,560 prostate cancer cases from the International Consortium of Prostate Cancer Genetics confirms the role of reported prostate cancer associated SNPs for familial disease
Int Consortium Prostate Canc Genet, Teerlink Cc, Thibodeau Sn, Mcdonnell Sk, Schaid Dj, Rinckleb A, et al
HUMAN GENETICS 2014;133(3):347-56

Atorvastatin prevents ATP-driven invasiveness via P2X7 and EHBP1 signaling in PTEN-expressing prostate cancer cells
Ghalali A, Wiklund F, Zheng H, Stenius U, Högberg J
Carcinogenesis 2014;35(7):1547-55

Body mass index and weight change in men with prostate cancer: progression and mortality
Bonn Se, Wiklund F, Sjölander A, Szulkin R, Stattin P, Holmberg E, et al
Cancer causes & control : CCC 2014;25(8):933-43

Fine-mapping the HOXB region detects common variants tagging a rare coding allele: evidence for synthetic association in prostate cancer
Saunders Ej, Dadaev T, Leongamornlert Da, Jugurnauth-little S, Tymrakiewicz M, Wiklund F, et al
PLoS genetics 2014;10(2):e1004129-

Immunohistochemical profile of ductal adenocarcinoma of the prostate
Seipel Ah, Samaratunga H, Delahunt B, Wiklund F, Wiklund P, Lindberg J, et al
Virchows Archiv : an international journal of pathology 2014;465(5):559-65

N-acetyl-L-aspartyl-L-glutamate peptidase-like 2 is overexpressed in cancer and promotes a pro-migratory and pro-metastatic phenotype
Whitaker Hc, Shiong Ll, Kay Jd, Grönberg H, Warren Ay, Seipel A, et al
Oncogene 2014;33(45):5274-87

A genome-wide assessment of variability in human serum metabolism
Hong Mg, Karlsson R, Magnusson Pk, Lewis Mr, Isaacs W, Zheng Ls, et al
Human mutation 2013;34(3):515-24

A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease
Practical Consortium, Australian Prostate Canc, Uk Protect Study Collaborators, British Assoc Urological Surg, Al Olama Aa, Kote-jarai Z, et al
HUMAN MOLECULAR GENETICS 2013;22(2):408-15

Exome sequencing of prostate cancer supports the hypothesis of independent tumour origins
Lindberg J, Klevebring D, Liu W, Neiman M, Xu J, Wiklund P, et al
European urology 2013;63(2):347-53

Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression
Practical Consortium, Uk Protect Study Collaborators, Uk Genetic Prostate Canc, Cogs-cruk Gwas-ellipse Part, Kote-jarai Z, Saunders Ej, et al
HUMAN MOLECULAR GENETICS 2013;22(12):2520-8

Genetic Score Is an Objective and Better Measurement of Inherited Risk of Prostate Cancer than Family History
Sun Jl, Na R, Hsu Fc, Zheng Sl, Wiklund F, Condreay Ld, et al
EUROPEAN UROLOGY 2013;63(3):585-7

Genetic variation in AKT1, PTEN and the 8q24 locus, and the risk of testicular germ cell tumor
Andreassen Ke, Kristiansen W, Karlsson R, Aschim El, Dahl O, Fossa Sd, et al
HUMAN REPRODUCTION 2013;28(7):1995-2002

Genome-wide Association Study Identifies Loci at ATF7IP and KLK2 Associated with Percentage of Circulating Free PSA
Jin Gf, Zheng Sl, Lilja H, Kim St, Tao S, Gao Zr, et al
NEOPLASIA 2013;15(1):95-101

Histopathological features of ductal adenocarcinoma of the prostate in 1,051 radical prostatectomy specimens
Seipel Ah, Wiklund F, Wiklund Np, Egevad L
Virchows Archiv : an international journal of pathology 2013;462(4):429-36

HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG)
Int Consortium Prostate Canc Genet, Xu Jf, Lange Em, Lu Ly, Zheng Sql, Wang Z, et al
HUMAN GENETICS 2013;132(1):5-14

Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array
Practical Prostate Canc Assoc Grp, Uk Protect Prostate Testing Canc, Uk Genetic Prostate Canc Study, Australian Prostate Canc, Cogs-canc Res Uk Gwas-ellipse Part, Eeles Ra, et al
NATURE GENETICS 2013;45(4):385-91

Investigation of six testicular germ cell tumor susceptibility genes suggests a parent-of-origin effect in SPRY4
Karlsson R, Andreassen Ke, Kristiansen W, Aschim El, Bremnes Rm, Dahl O, et al
HUMAN MOLECULAR GENETICS 2013;22(16):3373-80

Prognostic significance of histopathological features of extraprostatic extension of prostate cancer
Danneman D, Wiklund F, Wiklund Np, Egevad L
HISTOPATHOLOGY 2013;63(4):580-9

Prognostic significance of patterns of seminal vesicle invasion in prostate cancer
Kristiansen A, Wiklund F, Wiklund P, Egevad L
Histopathology 2013;62(7):1049-56

The mitochondrial and autosomal mutation landscapes of prostate cancer
Lindberg J, Mills Ig, Klevebring D, Liu W, Neiman M, Xu J, et al
European urology 2013;63(4):702-8

Analysis of Xq27-28 linkage in the international consortium for prostate cancer genetics (ICPCG) families
Int Consortium Prostate Canc Genet, Bailey-wilson Je, Childs Ej, Cropp Cd, Schaid Dj, Xu Jf, et al
BMC MEDICAL GENETICS 2012;:46-

Chromosomes 4 and 8 implicated in a genome wide SNP linkage scan of 762 prostate cancer families collected by the ICPCG
Int Consortium Prostate Canc, Lu Ly, Cancel-tassin G, Valeri A, Cussenot O, Lange Em, et al
PROSTATE 2012;72(4):410-26

Combining 33 genetic variants with prostate-specific antigen for prediction of prostate cancer: longitudinal study
Johansson M, Holmstrom B, Hinchliffe Sr, Bergh A, Stenman Uh, Hallmans G, et al
INTERNATIONAL JOURNAL OF CANCER 2012;130(1):129-37

FACT: An Open-Label Randomized Phase III Study of Fulvestrant and Anastrozole in Combination Compared With Anastrozole Alone As First-Line Therapy for Patients With Receptor-Positive Postmenopausal Breast Cancer
Bergh J, Jonsson Pe, Lidbrink Ek, Trudeau M, Eiermann W, Brattstrom D, et al
JOURNAL OF CLINICAL ONCOLOGY 2012;30(16):1919-25

Gene variations in sex hormone pathways and the risk of testicular germ cell tumour: a case-parent triad study in a Norwegian-Swedish population
Kristiansen W, Andreassen Ke, Karlsson R, Aschim El, Bremnes Rm, Dahl O, et al
HUMAN REPRODUCTION 2012;27(5):1525-35

Genome-wide association study in Chinese men identifies two new prostate cancer risk loci at 9q31.2 and 19q13.4
Xu Jf, Mo Zn, Ye Dw, Wang Ml, Liu F, Jin Gf, et al
NATURE GENETICS 2012;44(11):1231-5

Prostate cancer risk variants are not associated with disease progression
Szulkin R, Holmberg E, Stattin P, Xu Jf, Zheng Sg, Palmgren J, et al
PROSTATE 2012;72(1):30-9

Validation of prostate cancer risk-related loci identified from genome-wide association studies using family-based association analysis: evidence from the International Consortium for Prostate Cancer Genetics (ICPCG)
Jin Gf, Lu Ly, Cooney Ka, Ray Am, Zuhlke Ka, Lange Em, et al
HUMAN GENETICS 2012;131(7):1095-103

Early detection of prostate cancer with emphasis on genetic markers
Aly M, Wiklund F, Gronberg H
ACTA ONCOLOGICA 2011;:18-23

Fine mapping of a region of chromosome 11q13 reveals multiple independent loci associated with risk of prostate cancer
Chung Cc, Ciampa J, Yeager M, Jacobs Kb, Berndt Si, Hayes Rb, et al
HUMAN MOLECULAR GENETICS 2011;20(14):2869-78

Genetic Variants in the LEPR, CRY1, RNASEL, IL4, and ARVCF Genes Are Prognostic Markers of Prostate Cancer-Specific Mortality
Lin Dw, Fitzgerald Lm, Fu R, Kwon Em, Zheng Sl, Kolb S, et al
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 2011;20(9):1928-36

Genome-wide association study identifies new prostate cancer susceptibility loci
Schumacher Fr, Berndt Si, Siddiq A, Jacobs Kb, Wang Zm, Lindstrom S, et al
HUMAN MOLECULAR GENETICS 2011;20(19):3867-75

Genome-wide copy-number variation analysis identifies common genetic variants at 20p13 associated with aggressiveness of prostate cancer
Jin Gf, Sun Js, Liu Wn, Zhang Z, Chu Lw, Kim St, et al
CARCINOGENESIS 2011;32(7):1057-62

Inherited Genetic Markers Discovered to Date Are Able to Identify a Significant Number of Men at Considerably Elevated Risk for Prostate Cancer
Sun Jl, Kader Ak, Hsu Fc, Kim St, Zhu Y, Turner Ar, et al
PROSTATE 2011;71(4):421-30

Large-scale fine mapping of the HNF1B locus and prostate cancer risk
Berndt Si, Sampson J, Yeager M, Jacobs Kb, Wang Zm, Hutchinson A, et al
HUMAN MOLECULAR GENETICS 2011;20(16):3322-9

Polygenic Risk Score Improves Prostate Cancer Risk Prediction: Results from the Stockholm-1 Cohort Study
Aly M, Wiklund F, Xu Jf, Isaacs Wb, Eklund M, D'amato M, et al
EUROPEAN UROLOGY 2011;60(1):21-8

Prospective Seroepidemiologic Study of Human Papillomavirus and Other Risk Factors in Cervical Cancer
Dahlstrom La, Andersson K, Luostarinen T, Thoresen S, Ogmundsdottir H, Tryggvadottir L, et al
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 2011;20(12):2541-50

Risk of Prostate Cancer after Trans Urethral Resection of BPH: A Cohort and Nested Case-Control Study
Karlsson Ct, Wiklund F, Grönberg H, Bergh A, Melin B
Cancers 2011;3(4):4127-38

Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study
Practctical Consortium, Australian Prostate Canc Bioresour, Uk Protect Study Collaborators, Uk Genetic Prostate Canc Study Col, Kote-jarai Z, Al Olama Aa, et al
NATURE GENETICS 2011;43(8):785-91

A comprehensive study of the association between the EGFR and ERBB2 genes and glioma risk
Andersson U, Schwartzbaum J, Wiklund F, Sjostrom S, Liu Yh, Tsavachidis S, et al
ACTA ONCOLOGICA 2010;49(6):767-75

A COMPREHENSIVE STUDY OF THE ASSOCIATION BETWEEN THE EGFR AND ERBB2 GENES AND GLIOMA RISK
Andersson U, Scwartzbaum J, Wiklund F, Sjostrom S, Liu Y, Tsavachidis S, et al
NEURO-ONCOLOGY 2010;:17-17

A Missense Mutation in the Aggrecan C-type Lectin Domain Disrupts Extracellular Matrix Interactions and Causes Dominant Familial Osteochondritis Dissecans
Stattin El, Wiklund F, Lindblom K, Onnerfjord P, Jonsson Ba, Tegner Y, et al
AMERICAN JOURNAL OF HUMAN GENETICS 2010;86(2):126-37

Analysis of lipid pathway genes indicates association of sequence variation near SREBF1/TOM1L2/ATPAF2 with dementia risk
Reynolds Ca, Hong Mg, Eriksson Uk, Blennow K, Wiklund F, Johansson B, et al
HUMAN MOLECULAR GENETICS 2010;19(10):2068-78

Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index
Magic, Speliotes Ek, Willer Cj, Berndt Si, Monda Kl, Thorleifsson G, et al
NATURE GENETICS 2010;42(11):937-48

Blood Biomarker Levels to Aid Discovery of Cancer-Related Single-Nucleotide Polymorphisms: Kallikreins and Prostate Cancer
Klein Rj, Hallden C, Cronin Am, Ploner A, Wiklund F, Bjartell As, et al
CANCER PREVENTION RESEARCH 2010;3(5):611-9

Comparison of Two Methods for Estimating Absolute Risk of Prostate Cancer Based on Single Nucleotide Polymorphisms and Family History
Hsu Fc, Sun Jl, Zhu Y, Kim St, Jin T, Zhang Z, et al
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 2010;19(4):1083-8

Familial Aggregation of Glioma: A Pooled Analysis
Gliogene Consortium, Scheurer Me, Etzel Cj, Liu M, Barnholtz-sloan J, Wiklund F, et al
AMERICAN JOURNAL OF EPIDEMIOLOGY 2010;172(10):1099-107

Genome-Wide Linkage Analysis of 1,233 Prostate Cancer Pedigrees From the International Consortium for Prostate Cancer Genetics Using Novel sum LINK and sum LOD Analyses
Int Consortium Prostate Canc Genet, Christensen Gb, Baffoe-bonnie Ab, George A, Powell I, Bailey-wilson Je, et al
PROSTATE 2010;70(7):735-44

Hundreds of variants clustered in genomic loci and biological pathways affect human height
Procardis Consortium, Allen Hl, Estrada K, Lettre G, Berndt Si, Weedon Mn, et al
NATURE 2010;467(7317):832-8

Inherited genetic variant predisposes to aggressive but not indolent prostate cancer
Xu Jf, Zheng Sl, Isaacs Sd, Wiley Ke, Wiklund F, Sun Jl, et al
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 2010;107(5):2136-40

Macrophage inhibitory cytokine-1 (MIC-1/GDF15): a new marker of all-cause mortality
Wiklund Fe, Bennet Am, Magnusson Pke, Eriksson Uk, Lindmark F, Wu Ly, et al
AGING CELL 2010;9(6):1057-64

Prostate cancer genomics: can we distinguish between indolent and fatal disease using genetic markers?
Wiklund F
Genome medicine 2010;2(7):45-

Refining the Prostate Cancer Genetic Association within the JAZF1 Gene on Chromosome 7p15.2
Prokunina-olsson L, Fu Yp, Tang W, Jacobs Kb, Hayes Rb, Kraft P, et al
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 2010;19(5):1349-55

Sequence Variants in the TLR4 and TLR6-1-10 Genes and Prostate Cancer Risk. Results Based on Pooled Analysis from Three Independent Studies
Lindstrom S, Hunter Dj, Gronberg H, Stattin P, Wiklund F, Xu Jf, et al
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 2010;19(3):873-6

Toward Next Generation Plasma Profiling via Heat-induced Epitope Retrieval and Array-based Assays
Schwenk Jm, Igel U, Neiman M, Langen H, Becker C, Bjartell A, et al
MOLECULAR & CELLULAR PROTEOMICS 2010;9(11):2497-507

A Novel Prostate Cancer Susceptibility Locus at 19q13
Hsu Fc, Sun Jl, Wiklund F, Isaacs Sd, Wiley Ke, Purcell Ld, et al
CANCER RESEARCH 2009;69(7):2720-3

Association of a Germ-Line Copy Number Variation at 2p24.3 and Risk for Aggressive Prostate Cancer
Liu Wn, Sun Js, Li G, Zhu Y, Zhang S, Kim St, et al
CANCER RESEARCH 2009;69(6):2176-9

Association of Reported Prostate Cancer Risk Alleles With PSA Levels Among Men Without a Diagnosis of Prostate Cancer
Wiklund F, Zheng Sl, Sun Jl, Adami Ho, Lilja H, Hsu Fc, et al
PROSTATE 2009;69(4):419-27

A Survey of ABCA1 Sequence Variation Confirms Association with Dementia
Reynolds Ca, Hong Mg, Eriksson Uk, Blennow K, Bennet Am, Johansson B, et al
HUMAN MUTATION 2009;30(9):1348-54

Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial
Scandinavian Prostate Canc Grp Stu, Swedish Assoc Urological Oncology, Widmark A, Klepp O, Solberg A, Damber Je, et al
LANCET 2009;373(9660):301-8

Established Prostate Cancer Susceptibility Variants are not Associated with Disease Outcome
Wiklund Fe, Adami Ho, Zheng Sl, Stattin P, Isaacs Wb, Gronberg H, et al
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 2009;18(5):1659-62

Estimation of Absolute Risk for Prostate Cancer Using Genetic Markers and Family History
Xu Jf, Sun Jel, Kader Ak, Lindstrom S, Wiklund F, Hsu Fc, et al
PROSTATE 2009;69(14):1565-72

Fine-Mapping and Family-Based Association Analyses of Prostate Cancer Risk Variants at Xp11
Lu Ly, Sun Jl, Isaacs Sd, Wiley Ke, Smith S, Pruett K, et al
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 2009;18(7):2132-6

Fine mapping association study and functional analysis implicate a SNP in MSMB at 10q11 as a causal variant for prostate cancer risk
Chang Bl, Cramer Sd, Wiklund F, Isaacs Sd, Stevens Vl, Sun J, et al
HUMAN MOLECULAR GENETICS 2009;18(7):1368-75

First Results from FACT - An Open-Label, Randomized Phase III Study Investigating Loading Dose of Fulvestrant Combined with Anastrozole Versus Anastrozole at First Relapse in Hormone Receptor Positive Breast Cancer
Bergh J, Jonsson Pe, Lidbrink E, Trudeau M, Eiermann W, Brattstrom D, et al
CANCER RESEARCH 2009;69(24):490S-491S

Genetic and Plasma Variation of Insulin-Like Growth Factor Binding Proteins in Relation to Prostate Cancer Incidence and Survival
Johansson M, Mckay Jd, Rinaldi S, Wiklund F, Adami Ho, Gronberg H, et al
PROSTATE 2009;69(12):1281-91

Genetic Variants and Family History Predict Prostate Cancer Similar to Prostate-Specific Antigen
Zheng Sl, Sun Jl, Wiklund F, Gao Zg, Stattin P, Purcell Ld, et al
CLINICAL CANCER RESEARCH 2009;15(3):1105-11

Genetic Variation in the SST Gene and its Receptors in Relation to Circulating Levels of Insulin-Like Growth Factor-I, IGFBP3, and Prostate Cancer Risk
Johansson M, Mckay Jd, Wiklund F, Rinaldi S, Hallmans G, Balter K, et al
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 2009;18(5):1644-50

Genetic variation in the upstream region of ERG and prostate cancer
Lindstrom S, Adami Ho, Balter K, Xu Jf, Zheng Sl, Sun Jl, et al
CANCER CAUSES & CONTROL 2009;20(7):1173-80

Identification of a new prostate cancer susceptibility locus on chromosome 8q24
Yeager M, Chatterjee N, Ciampa J, Jacobs Kb, Gonzalez-bosquet J, Hayes Rb, et al
NATURE GENETICS 2009;41(10):1055-7

Is Genetic Background Important in Lung Cancer Survival?
Lindstrom Ls, Hall P, Hartman M, Wiklund F, Czene K
PLOS ONE 2009;4(5):e5588-

Macrophage Inhibitory Cytokine 1: A New Prognostic Marker in Prostate Cancer
Brown Da, Lindmark F, Stattin P, Balter K, Adami Ho, Zheng Sl, et al
CLINICAL CANCER RESEARCH 2009;15(21):6658-64

Quality of life in patients with locally advanced prostate cancer given endocrine treatment with or without radiotherapy: 4-year follow-up of SPCG-7/SFUO-3, an open-label, randomised, phase III trial
Swedish Assoc Urological Oncology, Scandinavian Prostate Canc Grp Stu, Fransson P, Lund Ja, Damber Je, Klepp O, et al
LANCET ONCOLOGY 2009;10(4):370-80

Risk of Bilateral Renal Cell Cancer
Wiklund F, Tretli S, Choueiri Tk, Signoretti S, Fall K, Adami Ho
JOURNAL OF CLINICAL ONCOLOGY 2009;27(23):3737-41

Sequence Variants at 22q13 Are Associated with Prostate Cancer Risk
Sun Jl, Zheng Sl, Wiklund F, Isaacs Sd, Li G, Wiley Ke, et al
CANCER RESEARCH 2009;69(1):10-5

Toll-like Receptor Signaling Pathway Variants and Prostate Cancer Mortality
Stark Jr, Wiklund F, Gronberg H, Schumacher F, Sinnott Ja, Stampfer Mj, et al
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 2009;18(6):1859-63

Two Independent Prostate Cancer Risk-Associated Loci at 11q13
Zheng Sl, Stevens Vl, Wiklund F, Isaacs Sd, Sun Jl, Smith S, et al
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 2009;18(6):1815-20

A multigenic approach to evaluating prostate cancer risk in a systematic replication study
Hsu Fc, Lindstrom S, Sun Jl, Wiklund F, Chen Sh, Adami Ho, et al
CANCER GENETICS AND CYTOGENETICS 2008;183(2):94-8

Association of prostate cancer risk variants with clinicopathologic characteristics of the disease
Xu Jf, Isaacs Sd, Sun Jl, Li G, Wiley Ke, Zhu Y, et al
CLINICAL CANCER RESEARCH 2008;14(18):5819-24

Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer
Gudmundsson J, Sulem P, Rafnar T, Bergthorsson Jt, Manolescu A, Gudbjartsson D, et al
NATURE GENETICS 2008;40(3):281-3

Cumulative association of five genetic variants with prostate cancer
Zheng Sl, Sun Jl, Wiklund F, Smith S, Stattin P, Li G, et al
NEW ENGLAND JOURNAL OF MEDICINE 2008;358(9):910-9

Cumulative effect of five genetic variants on prostate cancer risk in multiple study populations
Sun Jl, Chang Bl, Isaacs Sd, Wiley Ke, Wiklund F, Stattin P, et al
PROSTATE 2008;68(12):1257-62

Evidence for two independent prostate cancer risk-associated loci in the HNF1B gene at 17q12
Sun J, Zheng Sl, Wiklund F, Isaacs Sd, Purcell Ld, Gao Z, et al
NATURE GENETICS 2008;40(10):1153-5

Interaction between Single Nucleotide Polymorphisms in Selenoprotein P and Mitochondrial Superoxide Dismutase Determines Prostate Cancer Risk
Cooper Ml, Adami Ho, Gronberg H, Wiklund F, Green Fr, Rayman Mp
CANCER RESEARCH 2008;68(24):10171-7

Lifetime total physical activity and prostate cancer risk: a population-based case-control study in Sweden
Wiklund F, Lageros Yt, Chang E, Balter K, Johansson Je, Adami Ho, et al
EUROPEAN JOURNAL OF EPIDEMIOLOGY 2008;23(11):739-46

Y Chromosome Haplotypes and Prostate Cancer in Sweden
Lindstrom S, Adami Ho, Adolfsson J, Wiklund F
CLINICAL CANCER RESEARCH 2008;14(20):6712-6

Association of frequent consumption of fatty fish with prostate cancer risk is modified by COX-2 polymorphism
Hedelin M, Chang Et, Wiklund F, Bellocco R, Klint A, Adolfsson J, et al
INTERNATIONAL JOURNAL OF CANCER 2007;120(2):398-405

Compelling evidence for a prostate cancer gene at 22q12.3 by the International Consortium for Prostate Cancer Genetics
Int Consortium Prostate Canc Genet, Camp Nj, Cannon-albright La, Farnham Jm, Baffoe-bonnie Ab, George A, et al
HUMAN MOLECULAR GENETICS 2007;16(11):1271-8

Comprehensive evaluation of genetic variation in the IGF1 gene and risk of prostate cancer
Johansson M, Mckay Jd, Stattin P, Canzian F, Boillot C, Wiklund F, et al
INTERNATIONAL JOURNAL OF CANCER 2007;120(3):539-42

Familial concordance in cancer survival: a Swedish population-based study
Lindstrom Ls, Hall P, Hartman M, Wiklund F, Gronberg H, Czene K
LANCET ONCOLOGY 2007;8(11):1001-6

GLIOGENE - an international consortium to understand familial glioma
Malmer B, Adatto P, Armstrong G, Barnholtz-sloan J, Bernstein Jl, Claus E, et al
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 2007;16(9):1730-4

Haplotype-based analysis of common variation in the growth hormone receptor gene and prostate cancer risk
Mckay Jd, Kaaks R, Johansson M, Biessy C, Wiklund F, Balter K, et al
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 2007;16(1):169-73

Implications for prostate cancer of insulin-like growth factor-I (IGF-I) genetic variation and circulating IGF-I levels
Johansson M, Mckay Jd, Wiklund F, Rinaldi S, Verheus M, Van Gils Ch, et al
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM 2007;92(12):4820-6

Inherited variation in hormone-regulating genes and prostate cancer survival
Lindstrom S, Adami Ho, Balter Ka, Xu J, Zheng Sl, Stattin P, et al
CLINICAL CANCER RESEARCH 2007;13(17):5156-61

Lactase persistence, dietary intake of milk, and the risk for prostate cancer in Sweden and Finland
Torniainen S, Hedelin M, Autio V, Rasinpera H, Balter Ka, Klint A, et al
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 2007;16(5):956-61

No link between viral findings in the prostate and subsequent cancer development
Bergh J, Marklund I, Gustavsson C, Wiklund F, Gronberg H, Allard A, et al
BRITISH JOURNAL OF CANCER 2007;96(1):137-9

The MTHFR 677C -> T polymorphism and risk of prostate cancer: results from the CAPS study
Johansson M, Van Guelpen B, Hultdin J, Wiklund F, Adami Ho, Balter K, et al
CANCER CAUSES & CONTROL 2007;18(10):1169-74

Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB21P
Duggan D, Zheng Sl, Knowlton M, Benitez D, Dimitrov L, Wiklund F, et al
JOURNAL OF THE NATIONAL CANCER INSTITUTE 2007;99(24):1836-44

A common variant associated with prostate cancer in European and African populations
Amundadottir Lt, Sulem P, Gudmundsson J, Helgason A, Baker A, Agnarsson Ba, et al
NATURE GENETICS 2006;38(6):652-8

A comprehensive association study for genes in inflammation pathway provides support for their roles in prostate cancer risk in the CAPS study
Zheng Sl, Liu Wn, Wiklund F, Dimitrov L, Balter K, Sun Jl, et al
PROSTATE 2006;66(14):1556-64

Association between the presence of bacterial 16S RNA in prostate specimens taken during transurethral resection of prostate and subsequent risk of prostate cancer (Sweden)
Alexeyev O, Bergh J, Marklund I, Thellenberg-karlsson C, Wiklund F, Gronberg H, et al
CANCER CAUSES & CONTROL 2006;17(9):1127-33

Attitude towards remission induction for elderly patients with acute myeloid leukemia influences survival
Swedish Adult Acute Leukemia Regis, Juliusson G, Billstrom R, Gruber A, Hellstrom-linderg E, Hoglund M, et al
LEUKEMIA 2006;20(1):42-7

Breast cancer as a second primary in patients with prostate cancer - Estrogen treatment or association with family history of cancer?
Karlsson Ct, Malmer B, Wiklund F, Gronberg H
JOURNAL OF UROLOGY 2006;176(2):538-43

Detection of adeno-associated virus type 2 genome in cervical carcinoma
Zheng By, Li Xd, Wiklund F, Chowdhry S, Angstrom T, Hallmans G, et al
BRITISH JOURNAL OF CANCER 2006;94(12):1913-7

Dietary intake of phytoestrogens, estrogen receptor-beta polymorphisms and the risk of prostate cancer
Hedelin M, Balter Ka, Chang Et, Bellocco R, Klint A, Johansson Je, et al
PROSTATE 2006;66(14):1512-20

Estrogen receptor beta polymorphism is associated with prostate cancer risk
Thellenberg-karlsson C, Lindstrom S, Malmer B, Wiklund F, Augustsson-balter K, Adami Ho, et al
CLINICAL CANCER RESEARCH 2006;12(6):1936-41

Genetic polymorphism of chemokine receptors CCR2 and CCR5 in Swedish cervical cancer patients
Zheng B, Wiklund F, Gharizadeh B, Sadat M, Gambelunghe G, Hallmans G, et al
ANTICANCER RESEARCH 2006;26(5B):3669-74

Genetic variation in the COX-2 gene and the association with prostate cancer risk
Shahedi K, Lindstrom S, Zheng Sl, Wiklund F, Adolfsson J, Sun J, et al
INTERNATIONAL JOURNAL OF CANCER 2006;119(3):668-72

Germ-line genetic variation in the key androgen-regulating genes androgen receptor, cytochrome P450, and steroid-5-alpha-reductase type 2 is important for prostate cancer development
Lindstrom S, Wiklund F, Adami Ho, Balter Ka, Adolfsson J, Gronberg H
CANCER RESEARCH 2006;66(22):11077-83

High risk of contralateral breast carcinoma in women with hereditary/familial non-BRCA1/BRCA2 breast carcinoma
Shahedi K, Emanuelsson M, Wiklund F, Gronberg H
CANCER 2006;106(6):1237-42

Interactions of sequence variants in interieukin-1 receptor-associated kinase4 and the Toll-like receptor 6-1-10 gene cluster increase prostate cancer risk
Sun Jl, Wiklund F, Hsu Fc, Balter K, Zheng Sl, Johansson Je, et al
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 2006;15(3):480-5

Systematic replication study of reported genetic associations in prostate cancer: Strong support for genetic variation in the androgen pathway
Lindstrom S, Zheng Sl, Wiklund F, Jonsson Ba, Adami Ho, Balter Ka, et al
PROSTATE 2006;66(16):1729-43

Two-locus genome-wide linkage scan for prostate cancer susceptibility genes with an interaction effect
Chang Bl, Lange Em, Dimitrov L, Valis Cj, Gillanders Em, Lange La, et al
HUMAN GENETICS 2006;118(6):716-24

A combined genomewide linkage scan of 1,233 families for prostate cancer-susceptibility genes conducted by the international consortium for prostate cancer genetics
Actane Consortium, Xu Jf, Dimitrov L, Chang Bl, Adams Ts, Turner Ar, et al
AMERICAN JOURNAL OF HUMAN GENETICS 2005;77(2):219-29

Comprehensive genetic evaluation of common E-cadherin sequence variants and prostate cancer risk: strong confirmation of functional promoter SNP
Lindstrom S, Wiklund F, Jonsson Ba, Adami Ho, Balter K, Brookes Aj, et al
HUMAN GENETICS 2005;118(3-4):339-47

Interleukin-1 receptor antagonist haplotype associated with prostate cancer risk
Lindmark F, Zheng Sl, Wiklund F, Balter Ka, Sun J, Chang B, et al
BRITISH JOURNAL OF CANCER 2005;93(4):493-7

Results of second-look resection after primary resection of T1 tumour of the urinary bladder
Jahnson S, Wiklund F, Duchek M, Mestad O, Rintala E, Hellsten S, et al
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY 2005;39(3):206-10

Sequence variants in toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk
Sun Jl, Wiklund F, Zheng Sl, Chang Bl, Balter K, Li Lw, et al
JOURNAL OF THE NATIONAL CANCER INSTITUTE 2005;97(7):525-32

The interaction of four genes in the inflammation pathway significantly predicts prostate cancer risk
Xu Jf, Lowey J, Wiklund F, Sun Jl, Lindmark F, Hsu Fc, et al
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 2005;14(11):2563-8

Two Swedish founder MSH6 mutations, one nonsense and one missense, conferring high cumulative risk of Lynch syndrome
Cederquist K, Emanuelsson M, Wiklund F, Golovleva I, Palmqvist R, Gronberg H
CLINICAL GENETICS 2005;68(6):533-41

-160C/A polymorphism in the E-cadherin gene promoter and risk of hereditary, familial and sporadic prostate cancer
Jonsson Ba, Adami Ho, Hagglund M, Bergh A, Goransson I, Stattin P, et al
INTERNATIONAL JOURNAL OF CANCER 2004;109(3):348-52

Combined genome-wide scan for prostate cancer susceptibility genes
Gillanders Em, Xu Jf, Chang Bl, Lange Em, Wiklund F, Bailey-wilson Je, et al
JOURNAL OF THE NATIONAL CANCER INSTITUTE 2004;96(16):1240-7

Genetic analysis of the RNASEL gene in hereditary, familial, and sporadic prostate cancer
Wiklund F, Jonsson Ba, Brookes Aj, Stromqvist L, Adolfsson J, Emanuelsson M, et al
CLINICAL CANCER RESEARCH 2004;10(21):7150-6

H6D polymorphism in macrophage-inhibitory cytokine-1 gene associated with prostate cancer
Lindmark F, Zheng Sl, Wiklund F, Bensen J, Balter Ka, Chang Bl, et al
JOURNAL OF THE NATIONAL CANCER INSTITUTE 2004;96(16):1248-54

Does prophylactic breast irradiation prevent antiandrogen-induced gynecomastia? Evaluation of 253 patients in the randomized Scandinavian trial SPCG-7/SFUO-3
Widmark A, Fossa Sd, Lundmo P, Damber Je, Vaage S, Damber L, et al
UROLOGY 2003;61(1):145-51

Genome-wide scan of Swedish families with hereditary prostate cancer: Suggestive evidence of linkage at 5q11.2 and 19p13.3
Wiklund F, Gillanders Em, Albertus Ja, Bergh A, Damber Je, Emanuelsson M, et al
PROSTATE 2003;57(4):290-7

Linkage analysis of prostate cancer susceptibility: confirmation of linkage at 8p22-23
Wiklund F, Jonsson Ba, Goransson I, Bergh A, Gronberg H
HUMAN GENETICS 2003;112(4):414-8

A population-based prospective study of Chlamydia trachomatis infection and cervical carcinoma
Wallin Kl, Wiklund F, Luostarinen T, Angstrom T, Anttila T, Bergman F, et al
INTERNATIONAL JOURNAL OF CANCER 2002;101(4):371-4

Linkage analysis of prostate cancer susceptibility: Confirmation of linkage at 8p22-23.
Wiklund F, Jonsson Ba, Goransson I, Gronberg H
AMERICAN JOURNAL OF HUMAN GENETICS 2002;71(4):242-242

Risk of invasive cervical cancer associated with polymorphic HLA DR/DQ haplotypes
Ghaderi M, Wallin Kl, Wiklund F, Zake Ln, Hallmans G, Lenner P, et al
INTERNATIONAL JOURNAL OF CANCER 2002;100(6):698-701

Mammography has poor sensitivity in women below 40 years with family history positive breast cancer.
Emanuelsson Me, Wiklund F, Carlson S, Gronberg H
AMERICAN JOURNAL OF HUMAN GENETICS 2001;69(4):432-432

Multiple primary malignancies: A predictor for hereditary cancer syndromes.
Wiklund F, Gronberg H
AMERICAN JOURNAL OF HUMAN GENETICS 2001;69(4):387-387

Tumor necrosis factor A and MHC class I chain related gene a (MIC-A) polymorphisms in Swedish patients with cervical cancer
Ghaderi M, Zake Ln, Wallin Kl, Wiklund F, Hallmans G, Lenner P, et al
HUMAN IMMUNOLOGY 2001;62(10):1153-8

Seroepidemiology of human papillomavirus type 73: A sexually transmitted low-risk virus
Wallin Kl, Van Doornum Gjj, Andersson-ellstrom A, Kallings I, Wiklund F, Hallmans G, et al
INTERNATIONAL JOURNAL OF CANCER 2000;85(3):353-7

Tumor necrosis factor a-11 and DR15-DQ6 (B*0602) haplotype increase the risk for cervical intraepithelial neoplasia in human papillomavirus 16 seropositive women in northern Sweden
Ghaderi M, Nikitina L, Peacock Cs, Hjelmstrom P, Hallmans G, Wiklund F, et al
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 2000;9(10):1067-70

Type specificity and significance of different isotypes of serum antibodies to human papillomavirus capsids
Wang Zh, Kjellberg L, Abdalla H, Wiklund F, Eklund C, Knekt P, et al
JOURNAL OF INFECTIOUS DISEASES 2000;181(2):456-62

Age specific risks of familial prostate carcinoma - A basis for screening recommendations in high risk populations
Gronberg H, Wiklund F, Damber Je
CANCER 1999;86(3):477-83

MICA gene polymorphism and the risk to develop cervical intraepithelial neoplasia
Ghaderi M, Hjelmstrom P, Hallmans G, Wiklund F, Lenner P, Dillner J, et al
HUMAN IMMUNOLOGY 1999;60(10):970-3

Serum antibodies against p53 in relation to cancer risk and prognosis in breast cancer: a population-based epidemiological study
Lenner P, Wiklund F, Emdin So, Arnerlov C, Eklund C, Hallmans G, et al
BRITISH JOURNAL OF CANCER 1999;79(5-6):927-32

Sexual behaviour and papillomavirus exposure in cervical intraepithelial neoplasia: a population-based case-control study
Kjellberg L, Wang Zh, Wiklund F, Edlund K, Angstrom T, Lenner P, et al
JOURNAL OF GENERAL VIROLOGY 1999;:391-8

Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer
Wallin Kl, Wiklund F, Angstrom T, Bergman F, Stendahl U, Wadell G, et al
NEW ENGLAND JOURNAL OF MEDICINE 1999;341(22):1633-8

A population-based study of human papillomavirus deoxyribonucleic acid testing for predicting cervical intraepithelial neoplasia
Kjellberg L, Wiklund F, Sjoberg I, Wadell G, Angstrom T, Dillner J, et al
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY 1998;179(6):1497-502

TNF-A11 allele increases the risk significantly for carcinoma cervix (CaCx) in DR15-DQ6 (B*0602) positive patients.
Sanjeevi Cb, Ghaderi M, Peacock Cs, Hjelmstrom P, Hallmans G, Wiklund F, et al
HUMAN IMMUNOLOGY 1997;:49-49

A prospective study on the risk of cervical intra-epithelial neoplasia among healthy subjects with serum antibodies to HPV compared with HPV DNA in cervical smears
Chua Kl, Wiklund F, Lenner P, Angstrom T, Hallmans G, Bergman F, et al
INTERNATIONAL JOURNAL OF CANCER 1996;68(1):54-9

Different HLA-DR-DQ haplotypes are associated with cervical intraepithelial neoplasia among human papillomavirus type-16 seropositive and seronegative Swedish women
Sanjeevi Cb, Hjelmstrom P, Hallmans G, Wiklund F, Lenner P, Angstrom T, et al
INTERNATIONAL JOURNAL OF CANCER 1996;68(4):409-14

HLA-DQ6 (B*0602) is associated with human pappiloma virus (HPV) type 18, 33 antibody negative carcinoma cervix (CaCx) patients.
Sanjeevi Cb, Hjelmstrom P, Hallmans G, Wiklund F, Lenner P, Dillner J, et al
HUMAN IMMUNOLOGY 1996;:55-55

ANTIBODIES AGAINST LINEAR AND CONFORMATIONAL EPITOPES OF HUMAN PAPILLOMAVIRUS TYPE-16 THAT INDEPENDENTLY ASSOCIATE WITH INCIDENT CERVICAL-CANCER
Dillner J, Wiklund F, Lenner P, Eklund C, Fredrikssonshanazarian V, Schiller Jt, et al
INTERNATIONAL JOURNAL OF CANCER 1995;60(3):377-82

SERUM ANTIBODY-RESPONSES AGAINST HUMAN PAPILLOMAVIRUS IN RELATION TO TUMOR CHARACTERISTICS, RESPONSE TO TREATMENT, AND SURVIVAL IN CARCINOMA OF THE UTERINE CERVIX
Lenner P, Dillner J, Wiklund F, Hallmans G, Stendahl U
CANCER IMMUNOLOGY IMMUNOTHERAPY 1995;40(3):201-5

Visa alla publikationer

Karta